Ophthalmology Advisor

✨ February is #AgeRelatedMacularDegeneration (AMD) Awareness Month and we'd like to take a moment to share with our #EyeCare community some of the latest news regarding #AMD. 1️⃣ Study: First FDA-Cleared Home OCT AI System Reliably Segments nAMD Biomarkers 🔗: https://bit.ly/3EGcFFh 2️⃣Obstructive Sleep Apnea Elevates Risk for Age-Related Macular Degeneration 🔗: https://bit.ly/40NIeo3 3️⃣ Implantable Miniature Telescope Improves Vision in AMD With Manageable Risks 🔗: https://bit.ly/4b6N4S7 4️⃣Omega-3 Fatty Acids Protective Against Age-Related Macular Degeneration 🔗: https://bit.ly/3Wer1ms 5️⃣ SD-OCT Outperforms Fluorescein Angiography, Color Imaging in Detecting Fibrosis in nAMD 🔗: https://bit.ly/3PUa4tF 6️⃣ Quarter of Medicare Advantage Members With GA Have Concurrent Wet AMD 🔗: https://bit.ly/4jqAMb0 7️⃣ NORSE Eight Trial: Intravitreal Bevacizumab Noninferior to Ranibizumab for Wet AMD 🔗: https://bit.ly/3WzFPMr Read more about AMD here ➡️: https://bit.ly/3QxTEYe Action Against AMD (Age-Related Macular Degeneration), AMD Alliance International, Inc., Macular Society, American Academy of Ophthalmology ---------------------- #MacularDegeneration #WetAMD #DryAMD #OCTA #AI #MedTech #NotalVision #SCANLYHOMEOCT #nAMD #Ophthalmology #Ophthalmologist #EyeHealth #EyeCare #EyeDoctor #CentralVisionLoss #ObstructiveSleepApnea #OSA #SleepApnea #SINGIMT #VisionLoss #GeographicAtrophy #GA #VisualOutcomes #BCVA #Omega3 #Omega3FattyAcids #DocosahexaenoicAcid #PreventativeCare #SDOCT #OpticalCoherenceTomography #OCT #FluoresceinAngiography #ColorImaging #Fibrosis #NeovascularAgeRelatedMacularDegeneration #Medicare #MAPD #Pegecetacoplan #AvacincaptadPegol #AMDDiagnosis #NORSEEightTrial #ONS5010 #Ranibizumab #BevacizumabVikg

🧬 Several #GeneticTherapies for #RetinalDiseases are on the verge of graduating from #ClinicalTrial investigations to redefining treatment. In the last few years, #GeneTherapy has captured the attention of the broader medical community and made significant strides in clinical and scientific research. It’s transformed how physicians treat #GeneticDisease and #Cancer, offering treatments where, in many cases, none previously existed. Meaningful developments within #GeneTherapy can be found across many specialties, including #Ophthalmology. As an immune privileged organ, the eyes can tolerate #VectorBasedGeneTherapy (delivered intravitreally, subretinally, or suprachoroidally) exceptionally well, making them a great candidate for gene therapy among other reasons.1 Read more here ➡️: https://bit.ly/3EXGRfg 🌟 Written by Frida Velcani - an MD-MBA student at the Geisel School of Medicine at Dartmouth. She is dedicated to enhancing patient outcomes by expanding access to information about innovative treatments and aims to carry this commitment forward in her future career as an ophthalmologist. -------------------------------- #RareInheritedRetinalDisorders #MonogenicDiseases #BreakthroughTherapy #OrphanDrug #RareDisease #RPE65MediatedInheritedRetinalDystrophy #RetinalDystrophy #VoretigeneNeparvovecRzyl #Luxturna #SparksTherapeutics Spark Therapeutics, Inc. #OcularCare #AntiVEGFTreatments #AntiVEGF #VisualAcuity #MacularChoroidalNeovascularization #AgeRelatedMacularDegeneration #AMD #LegallyBlind #AdenoAssociatedViruses #AAV #ABBVRGX314 REGENXBIO #AAVIATETrial #NCT04514653 #BCVA #WetAMD #ADVM022 Adverum Biotechnologies #IOPTICTrial #NCT03748784 #CentralSubfieldThickness #LUNATrial #NCT05536973 #UBX1325 #2ENVISIONStudy #NCT05275205 #nAMD #DiabeticMacularEdema UNITY Biotechnology #DME #4D150 #PRISMPhaseTrial #4DMT #NCT05197270 #HG202 HuidaGene Therapeutics #CRISPR #NCT06623279 #BRIGHTTrial #RNAEditingTherapy #MCO010 Nanoscope Therapeutics Inc. #RetinitisPigmentosa #NCT04945772 #RESTORETrial #APX3330 Opus Genetics #NonProliferativeDiabeticRetinopathy #NPDR #ZETA1Trial #NCT04692688 #OCU400 Ocugen #NR2E3 #liMeliGhTClinicalTrial #NCT06388200 #PhotoreceptorDysfunction #AMDAwarenessMonth

Ophthalmology Dx: With An Atypical Membrane, The Pressure’s On Presented by: Celine Chaaya, MD, Shangjun Jiang, MD, & Nimesh Patel, MD of Massachusetts Eye and Ear Clinicians evaluate a pediatric patient with decreased vision, headaches, a sensation of pressure behind the eye, and an unusual retinal finding. Can you identify his diagnosis? Read the full case here ➡️: https://bit.ly/4i70yj8 #OphthalmologyDx #Ophthalmology #Ophthalmologist #MedicalCaseStudy #MedicalResident #EyeDoctor #EyeHealth #EyeCare #CaseStudy #Photophobia #FundusPhotograph #Retina #MedicalQuiz

From 2011 to 2022, there was an increase in the number of family caregivers providing help to older U.S. adults, according to a study published in the February issue of Health Affairs. Read more: https://bit.ly/3QE9f8F #FamilyCaregivers #Caregivers #MedicalNews

Long-term use of metformin and sulfonylureas (SUs), alone or in combination, reduces the risk of diabetic retinopathy (DR) in patients with newly diagnosed type 2 diabetes mellitus (T2DM), according to study results published in the International Journal of Retina and Vitreous. Read more: https://bit.ly/434Fjdw #Metformin #Sulfonylureas #SUs #DiabeticRetinopathy #Type2DiabetesMellitus #T2DM #Ophthalmology #EyeHealth #EyeCare #Ophthalmologist #EyeDoctor

The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association (JAMA). Read here: https://bit.ly/4h3Q9E4 #USAdults #SevereObesity #MedicalNews #HealthNews

Postpandemic hospital occupancy is higher than prepandemic and is expected to continue increasing without changes in the hospitalization rate or staffed hospital bed supply, according to a research letter published online Feb. 19 in JAMA Network Open. Read more: https://bit.ly/3QvXZLx #PostpandemicHospitalOccupancy #HospitalizationRate #HospitalBedSupply #MedicalNews

Patients with pregnancy-related hypertension (HTN) or diabetes are more likely to be screened for diabetes and dyslipidemia after delivery, but screening rates remain low for those with and without HTN and diabetes, according to a research letter published online Feb. 17 in Circulation (American Heart Association). Read here: https://bit.ly/3XiMLOy #PregnancyRelatedHypertension #HTN #WomensHealth #Diabetes #Dyslipidemia #EyeHealth #MedicalNews

Ten members of the House have introduced a bill that would put a stop to the 2.83% cut in Medicare physician reimbursement that went into effect at the beginning of this year.1-3 The bill would provide a payment update of 6.62% and would take effect on April 1. American Medical Association Read more: https://bit.ly/4ifSTPH #Medicare #MedicarePhysician #PhysicianReimbursement #MedicalNews

Semaglutide use in patients with type 2 diabetes (T2D) slightly increases the risk of nonarteritic anterior ischemic optic neuropathy (NAION), research published in JAMA Ophthalmology shows. The study leveraged the Observational Health Data Sciences and Informatics (OHDSI) network — an international open-science collaborative centered around the Observational Medical Outcomes Partnership (OMOP) Common DataModel (CDM) — to investigate the association between semaglutide use and NAION. Read here: https://bit.ly/415E8HW #Semaglutide #Type2Diabetes #T2D #Ophthalmology #Ophthalmologist #EyeCare #NeuroOphthalmology #NonarteriticAnteriorIschemicOpticNeuropathy #NAION